German Company: Trump didn't ask to buy the coronary vaccine just for Americans.

The German bio-farmacetic company CureVac, which has taken steps to find a vaccine against coronary, has exposed local media that the American government wants to buy it. German newspaper Wilt am Zontag reported on Sunday, citing unnamed sources from the German government that former General Director of CureVac Daniel Menichel was at a meeting of President Donald Trump with people in the pharmaceutical industry in early March.

Since March 11th, the company from Tibingen announced that Menicella was no longer its general manager, without giving any explanation of why. Even am Zontag stated that Trump offered CureVac a large sum of money to buy its company or technology, and thus the right to produce the anti-commercial vaccine now seen only for the American market.

Crevac confirmed at Titter that there was a meeting with Trump on March 2nd, but that media claims on Washington's bid were incorrect. ” CureVac did not receive an offer from the US government or relevant subjects before, during or after the White House Task Force meeting on March 2nd,”, writes the Tibingen-based company at Titanter. Even Health Minister Jens Spahn said the sale of the company by Tibingen is not under discussion, while Economy Minister Peter Altmayer said “German is not for sale”.I Asked by the media if the US tried to buy the company for a large sum of money, German Interior Minister Horst Zehofer said he “alone could say he has heard repeatedly from government members that this is true” . On the other hand, US Ambassador to Germany and National Intelligence Director Richard Green has denied claims by the newspaper Wilt am Zontag and other media, calling them false. Coronavius has so far been confirmed in nearly 180,000 people worldwide, and more than 7,000 have died.